Butyric Acid

Butyric Acid

SCHEMBL6730560

CC(C)Cn1cnc2c(CN)nc3ccccc3c21.CCCC(=O)O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 8/20 0.60
PDE4D Q08499 2/20 0.60
LMNA P02545 2/20 0.60
POLB P06746 1/20 0.60
HRH2 P25021 1/20 0.60
ADRA1D P25100 1/20 0.60
HTR2A P28223 1/20 0.60
ADORA2A P29274 1/20 0.60
ADRA1A P35348 1/20 0.60
NUDT1 P36639 1/20 0.60
HTR2B P41595 1/20 0.60
KCNH2 Q12809 1/20 0.60
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
APAF1 O14727 1/20 0.37
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 3/20 0.37
HPGD P15428 2/20 0.37
EGLN3 Q9H6Z9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL6726615 0.94 TLR7 (0.63) TLR7PDE4DLMNAPOLBHRH2
Butyric Acid SCHEMBL9388409 0.86 TLR7 (0.61) TLR7PDE4DLMNAPOLBHRH2
SCHEMBL24635178 0.82 TLR7 (0.70) TLR7PDE4DLMNAPOLBHRH2
Propionic Acid SCHEMBL9388385 0.79 TLR7 (0.63) TLR7PDE4DLMNAPOLBHRH2
Propionic Acid SCHEMBL6719538 0.78 TLR7 (0.62) TLR7PDE4DLMNAPOLBHRH2
Imiquimod SCHEMBL5262205 0.78 TLR7 (0.88) TLR7PDE4DLMNAPOLBHRH2
SCHEMBL487883 0.78 TLR7 (0.68) TLR7PDE4DLMNAPOLBHRH2
Glycine SCHEMBL3195843 0.78 TLR7 (0.61) TLR7PDE4DLMNAPOLBHRH2
Hydrochloric Acid SCHEMBL4540946 0.77 TLR7 (0.67) TLR7PDE4DLMNAPOLBHRH2
Imiquimod SCHEMBL3415170 0.76 TLR7 (0.84) TLR7PDE4DLMNAPOLBHRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040122231-A1 Process for preparing 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines 3M INNOVATIVE PROPERTIES COMPANY 2004-06-24 US claimed
US-20030212270-A1 Process for preparing 1-Substituted, 2-Substituted 1-H-Imidazo(4,5-c)quinolin-4-Amines 3M INNOVATIVE PROPERTIES COMPANY 2003-11-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212270-A1 Process for preparing 1-Substituted, 2-Substituted 1-H-Imidazo(4,5-c)quinolin-4-Amines IFNAR1, IRF3, IFNG TLR7 101/4885PDE4D 325/4885LMNA 2048/4885
US-20040122231-A1 Process for preparing 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines UGT1A4, QARS1, HTR4 TLR7 1287/4885PDE4D 484/4885LMNA 908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.